Sofie Biosciences
Highly Engaged Employees
Highly Engaged EmployeesManufacturing · Virginia, United States · 201-500 Employees
View Company Info for Free
Overview
Headquarters
21000 Atlantic Blvd Ste 730, Sterling, V...Phone Number
(703) 787-7900Website
www.sofie.comRevenue
$580.6 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
4
4
1
1
1
1
About Sofie Biosciences
The early vision for molecular imaging was to revolutionize clinical diagnostics and therapeutics to better understand and treat the biology of disease. SOFIE brings that vision to life by increasing the adoption and application diversity of theranostics by removing the cost and complexity traditionally associated with the technology. With a full line of imaging and radiochemistry systems and a premier radiopharmacy network and contract manufacturing organization to supply novel agents for diagnosis and therapy, SOFIE is dedicated to improving patient health.Explore more
Sofie Biosciences Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Sofie Biosciences your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check if Sofie Biosciences has recently received funding, and reach out quickly before it becomes old news!
Funding: Get notified immidiatlly once Sofie Biosciences has new funding data
Earning: See what the market has to say on Sofie Biosciences recently announced quarterly report
Sofie Biosciences, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when Sofie Biosciences launches new products
Check out if Sofie Biosciences is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at Sofie Biosciences
Click to see if Sofie Biosciences had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Reach out to Masked Content who joined Sofie Biosciences as Masked Content
Find 2 more new buyers
Compare Similar Companies to Sofie Biosciences
Compare insights from companies similar to Sofie Biosciences, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Sofie Biosciences
$580.6M
201-500
Private
$55.6M
2008
PP
Patrick PhelpsPresident, CEO & Board Member & Co-Founder
Company Profile Activity
Activity Insights
Sofie Biosciences is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Sofie Biosciences is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Sofie Biosciences.
Sofie Biosciences financials insights
Gather financial insights about Sofie Biosciences, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2013
Series A
$5M
2014
Grant
$1.5M
2016
Private Equity
$3.7M
2018
Series B
$16M
2020
Debt
$2M
Series C
$27.4M
Sofie Biosciences Tech Stack
A closer look at the technologies used by Sofie Biosciences
Most Recent Scoops
Hiring Plans
Sofie Biosciences has more open roles in Medical & Health than it has had at any time in the past 12 months.
Hiring Plans
Hiring Plans
Sofie Biosciences has more open roles in Operations than it has had at any time in the past 12 months. Areas of expertise include: Inventory Control, Warehousing, Equipment Calibration, Calendar Management, Microsoft Access, Control Operation, and Organizing Meetings.
Hiring Plans
Open Position
Person-Based
Hiring Plans
Hiring Plans
Sofie Biosciences News & Media
Trilantic North America Completes Strategic Growth Investment in SOFIE Biosciences
NEW YORK--(BUSINESS WIRE)--Trilantic North America, a growth-focused middle market private equity firm, announced today that it has made a substantial growth investment in SOFIE Biosciences ("SOFIE" or the "Company"), a founder-led radiopharmacy and contract development and manufacturing organization. The investment was made in partnership with SOFIE's founding team, who will retain a meaningful equity stake and continue to lead the business. Headquartered in Dulles, Virginia and with 15 locatiLife Molecular Imaging and SOFIE announce Neuraceq® availability in Cleveland
Improved supply capabilities of Neuraceq® to provide better patient access to beta-amyloid PET BOSTON, April 5, 2024 /PRNewswire/ -- Life Molecular Imaging (LMI) and SOFIE Biosciences (SOFIE), a national US manufacturer and developer of PET radiopharmaceuticals, announce that the...Jubilant co to sell stake in US firm for $139 million - Times of India
International Business News: NEW DELHI: Jubilant Pharmova's subsidiary Jubilant Pharma will sell its entire 25.Jubilant unit makes over five-fold gain by selling stake in US firm - VCCircle
Jubilant Pharma Ltd, a Singapore-based subsidiary of Mumbai-listed Jubilant Pharmova Ltd, will sell its entire stake in a US company as part of a larger ......
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Sofie Biosciences
Sign Up For FreeTo access detailed company insights
The early vision for molecular imaging was to revolutionize clinical diagnostics and therapeutics to better understand and treat the biology of disease. SOFIE brings that vision to life by increasing the adoption and application diversity of theranostics by removing the cost and complexity traditionally associated with the technology. With a full l... Read More
